Cargando…

Role of IL13RA2 in Sunitinib Resistance in Clear Cell Renal Cell Carcinoma

Vascular endothelial growth factor (VEGF) and mammalian target of rapamycin are well-known therapeutic targets for renal cell carcinoma (RCC). Sunitinib is an agent that targets VEGF receptors and is considered to be a standard treatment for metastatic or unresectable clear cell RCC (ccRCC). However...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shibasaki, Noboru, Yamasaki, Toshinari, Kanno, Toru, Arakaki, Ryuichiro, Sakamoto, Hiromasa, Utsunomiya, Noriaki, Inoue, Takahiro, Tsuruyama, Tatsuaki, Nakamura, Eijiro, Ogawa, Osamu, Kamba, Tomomi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4482605/ https://www.ncbi.nlm.nih.gov/pubmed/26114873 http://dx.doi.org/10.1371/journal.pone.0130980

Ejemplares similares

CCL2 as a potential therapeutic target for clear cell renal cell carcinoma
por: Arakaki, Ryuichiro, et al.
Publicado: (2016)

Functional and genomic characterization of patient‐derived xenograft model to study the adaptation to mTORC1 inhibitor in clear cell renal cell carcinoma
por: Sakamoto, Hiromasa, et al.
Publicado: (2020)

Detection of von Hippel‐Lindau gene mutation in circulating cell‐free DNA for clear cell renal cell carcinoma
por: Sumiyoshi, Takayuki, et al.
Publicado: (2021)

Extracellular vesicles secreted from bone metastatic renal cell carcinoma promote angiogenesis and endothelial gap formation in bone marrow in a time-dependent manner in a preclinical mouse model
por: Takeda, Masashi, et al.
Publicado: (2023)

Clinical utility of androgen receptor gene aberrations in circulating cell-free DNA as a biomarker for treatment of castration-resistant prostate cancer
por: Sumiyoshi, Takayuki, et al.
Publicado: (2019)

In Vitro HIV-1 Selective Integration into the Target Sequence and decoy-effect of the modified sequence
por: Tsuruyama, Tatsuaki
Publicado: (2011)

A Model of Cell Biological Signaling Predicts a Phase Transition of Signaling and Provides Mathematical Formulae
por: Tsuruyama, Tatsuaki
Publicado: (2014)

Kinetic stability analysis of protein assembly on the center manifold around the critical point
por: Tsuruyama, Tatsuaki
Publicado: (2017)

Information Thermodynamics Derives the Entropy Current of Cell Signal Transduction as a Model of a Binary Coding System
por: Tsuruyama, Tatsuaki
Publicado: (2018)

Analysis of Cell Signal Transduction Based on Kullback–Leibler Divergence: Channel Capacity and Conservation of Its Production Rate during Cascade
por: Tsuruyama, Tatsuaki
Publicado: (2018)

Entropy in Cell Biology: Information Thermodynamics of a Binary Code and Szilard Engine Chain Model of Signal Transduction
por: Tsuruyama, Tatsuaki
Publicado: (2018)

Information Thermodynamics of the Cell Signal Transduction as a Szilard Engine
por: Tsuruyama, Tatsuaki
Publicado: (2018)

The Conservation of Average Entropy Production Rate in a Model of Signal Transduction: Information Thermodynamics Based on the Fluctuation Theorem
por: Tsuruyama, Tatsuaki
Publicado: (2018)

Nonlinear model of infection wavy oscillation of COVID-19 in Japan based on diffusion kinetics
por: Tsuruyama, Tatsuaki
Publicado: (2022)

Kullback–Leibler Divergence of an Open-Queuing Network of a Cell-Signal-Transduction Cascade
por: Tsuruyama, Tatsuaki
Publicado: (2023)

Ten‐year outcomes of whole‐pelvic intensity‐modulated radiation therapy for prostate cancer with regional lymph node metastasis
por: Nakamura, Kiyonao, et al.
Publicado: (2022)

Experimental Evidence of Persistent Androgen-Receptor-Dependency in Castration-Resistant Prostate Cancer
por: Kobayashi, Takashi, et al.
Publicado: (2013)

In Vitro HIV-1 LTR Integration into T-Cell Activation Gene CD27 Segment and the Decoy Effect of Modified-Sequence DNA
por: Ohmori, Rei, et al.
Publicado: (2012)

Solitary recurrence of prostate cancer surrounded by seminal vesicle/vas deferens‐like epithelium
por: Takamori, Hajime, et al.
Publicado: (2020)

Response to sunitinib (Sutent) in chemotherapy refractory clear cell ovarian cancer
por: Alifrangis, C, et al.
Publicado: (2016)

Epidermal growth factor receptor cascade prioritizes the maximization of signal transduction
por: Kiso-Farnè, Kaori, et al.
Publicado: (2022)

Amino‐terminal enhancer of split gene AES encodes a tumor and metastasis suppressor of prostate cancer
por: Okada, Yoshiyuki, et al.
Publicado: (2017)

In Vitro Murine Leukemia Retroviral Integration and Structure Fluctuation of Target DNA
por: Tsuruyama, Tatsuaki, et al.
Publicado: (2012)

The safety and efficacy of sunitinib before planned nephrectomy in metastatic clear cell renal cancer
por: Powles, T., et al.
Publicado: (2011)

Dynamic epigenetic changes to VHL occur with sunitinib in metastatic clear cell renal cancer
por: Stewart, Grant D., et al.
Publicado: (2016)

Development of drugs targeting hypoxia‐inducible factor against tumor cells with VHL mutation: Story of 127 years
por: Takamori, Hajime, et al.
Publicado: (2023)

Clear cell carcinoma of the seminal vesicle in a young adult
por: Murakami, Hidetoshi, et al.
Publicado: (2022)

Outcome of different post-orchiectomy management for stage I seminoma: Japanese multi-institutional study including 425 patients
por: Kamba, Tomomi, et al.
Publicado: (2010)

Dysregulated HAI-2 Plays an Important Role in Renal Cell Carcinoma Bone Metastasis through Ligand-Dependent MET Phosphorylation
por: Yamasaki, Koji, et al.
Publicado: (2018)

Organ-specific and tumor-size-dependent responses to sunitinib in clear cell renal cell carcinoma
por: Tsuchiya, Norihiko, et al.
Publicado: (2014)

CXCL7 is a predictive marker of sunitinib efficacy in clear cell renal cell carcinomas
por: Dufies, Maeva, et al.
Publicado: (2017)

Cellular and physical microenvironments regulate the aggressiveness and sunitinib chemosensitivity of clear cell renal cell carcinoma
por: Nagase, Kei, et al.
Publicado: (2021)

Successful surgical management of recurrent urachal adenocarcinoma: A case report
por: Somiya, Shinya, et al.
Publicado: (2020)

Antitumor effect of WEE1 blockade as monotherapy or in combination with cisplatin in urothelial cancer
por: Murakami, Kaoru, et al.
Publicado: (2021)

HIF pathway and c-Myc as biomarkers for response to sunitinib in metastatic clear-cell renal cell carcinoma
por: Maroto, P, et al.
Publicado: (2017)

RhoA and vigilin are candidates for immunohistochemical markers for epithelioid malignant mesothelioma
por: Hiratsuka, Takuya, et al.
Publicado: (2022)

Castration-Resistant Prostate Cancer Refractory to Second-Generation Androgen Receptor Axis-Targeted Agents: Opportunities and Challenges
por: Kita, Yuki, et al.
Publicado: (2018)

Sunitinib treatment for patients with clear-cell metastatic renal cell carcinoma: clinical outcomes and plasma angiogenesis markers
por: Kontovinis, Loukas F, et al.
Publicado: (2009)

The efficacy and safety of irinotecan cisplatin and mitomycin chemotherapy in sunitinib pre-treated metastatic clear cell renal cancer
por: Powles, Thomas, et al.
Publicado: (2008)

Acute Acalculous Cholecystitis in Patients With Clear Cell Renal Cell Carcinoma Treated With Sunitinib: Report of Two Cases
por: Furubayashi, Nobuki, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ld511gd0opmkg2rll3j1ibb8aa